Impact of different case definitions for acute otitis media on the efficacy estimates of a pneumococcal conjugate vaccine

Vaccine

Volumn 26, Issue 20, 2008, Pages 2466-2470

  Palmu, Arto ^a,b   Jokinen, Jukka ^a   Kilpi, Terhi ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Conjugate vaccine; Otitis media; Streptococcus pneumoniae

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA TOXOID CRM197; DIPLOID CELL VACCINE; HEPATITIS B VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE;

ACUTE OTITIS MEDIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CONJUGATION; DRUG EFFICACY; EARDRUM; FOLLOW UP; HAEMOPHILUS INFLUENZAE; HELPER VIRUS; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

CHILD, PRESCHOOL; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; VACCINES, CONJUGATE;

EID: 42649090102     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.03.013     Document Type: Article

References (17)

1. Owings M.F., and Kozak L.J. Ambulatory and inpatient procedures in the United States, 1996. Vital Health Stat 13 139 (1998) 13
2. Wang E.E., Einarson T.R., Kellner J.D., and Conly J.M. Antibiotic prescribing for Canadian preschool children: evidence of overprescribing for viral respiratory infections. Clin Infect Dis 29 1 (1999) 155-160
3. Bluestone C.D., Stephenson J.S., and Martin L.M. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 11 Suppl 8 (1992) S7-S11
4. Kilpi T., Herva E., Kaijalainen T., Syrjänen R., and Takala A.K. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J 20 (2001) 654-662
5. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19 3 (2000) 187-195
6. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakoski J., Herva E., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. New Engl J Med 344 6 (2001) 403-409
7. Grijalva C., Poehling K., Nuorti J., Zhu Y., Martin S., Edwards K., et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics 118 3 (2006) 865-873
8. Prymula R., Peeters P., Chrobok V., Kriz P., Novakova E., Kaliskova E., et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367 9512 (2006) 740-748
9. Pratt, RD. Prevnar™, Pneumococcal Conjugate Vaccine 7-valent, for the Prevention of Acute Otitis Media. FDA Briefing Document for the Vaccines and Related Biological Products Advisory Committee (VRBPAC) May 21, 2002. Retrieved January 2, 2008 from http://www.fda.gov/OHRMS/DOCKETS/ac/02/briefing/3854B1_02.doc.
10. Kilpi T., Åhman H., Jokinen J., Lankinen K.S., Palmu A., Savolainen H., et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis 37 9 (2003) 1155-1164
11. Klein J.O. Lessons from recent studies on the epidemiology of otitis media. Pediatr Infect Dis J 13 11 (1994) 1031-1034
12. Lanphear B.P., Byrd R.S., Auinger P., and Hall C.B. Increasing prevalence of recurrent otitis media among children in the United States. Pediatrics 99 3 (1997) E1
13. Joki-Erkkilä V.P., Laippala P., and Pukander J. Increase in paediatric acute otitis media diagnosed by primary care in two Finnish municipalities-1994-5 versus 1978-9. Epidemiol Infect 121 3 (1998) 529-534
14. McCaig L., Besser R., and Hughes J. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 287 23 (2002) 3096-3102
15. Fleming D., Ross A., Cross K., and Kendall H. The reducing incidence of respiratory tract infection and its relation to antibiotic prescribing. Br J Gen Pract 53 495 (2003) 778-783
16. Fireman B., Black S.B., Shinefield H.R., Lee J., Lewis E., and Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 22 2 (2003) 10-16
17. Plasschaert A., Rovers M., Schilder A., Verheij T., and Hak E. Trends in doctor consultations, antibiotic prescription, and specialist referrals for otitis media in children: 1995-2003. Pediatrics 117 6 (2006) 1879-1886